You are here: Industry Insights > CHMP

News List

CHMP recommends just two new meds in Feb meeting pharmatimes
March 06, 2020
The European Medicines Agency’s (EMA) human medicines committee (CHMP) has recommended just two new medicines for approval at its February 2020 meeting, as well as three extensions of pre-existing therapies.
EMA releases results from February meeting, recommending two medicines EuropeanPharmaceuticalReview
March 03, 2020
The EMA has recommended granting marketing authorisation to two medicines and extending the indications for three more following its latest meeting.
Pfizer receives CHMP recommendation for rare cardiomyopathy drug pharmaceutical-technology
December 17, 2019
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the authorisation of Pfizer’s Vyndaqel (tafamidis) ...
CHMP recommends Biogen’s Plegridy and Avonex use in pregnancy pharmaceutical-technology
September 26, 2019
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the use of interferon beta therapies, including Biogen’s Plegridy and Avonex ...
CHMP recommends AstraZeneca’s Qtrilmet for type 2 diabetes pharmaceutical-technology
September 25, 2019
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the marketing authorisation of AstraZeneca’s Qtrilmet to treat type 2 diabetes in adults.
EMA CHMP recommends seven medicines for approval europeanpharmaceuticalreview
September 25, 2019
The EMA has suggested seven treatments to be granted marketing authorisations and also advocated indication extension for eight drugs.
CHMP issues approval of 13 medicines pharmaceutical-technology
July 30, 2019
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of 13 medicines for a variety of diseases.
CHMP issues positive opinion for AstraZeneca’s Fasenra Pen pharmaceutical-technology
July 04, 2019
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive recommendation for Fasenra Pen, a pre-filled, single-use auto-injector.
Imbruvica receives positive opinion from CHMP pharmaceutical-technology
July 03, 2019
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended expanding the existing marketing authorisation (MA) for Janssen’s Imbruvica (ibrutinib) to include chronic lymphocytic leukaemia (CLL) and Waldenst
AstraZeneca’s new formulation tablets receive positive CHMP opinion europeanpharmaceuticalreview
May 07, 2019
AstraZeneca’s new formulation tablets receive positive CHMP opinion.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page